Multicolor FISH in chronic lymphocytic leukemia. An interphase study of patients with early-onset disease

被引:5
作者
Doneda, L
Castorina, P
Tedeschi, A
Intropido, L
Morra, E
Montillo, M
Larizza, L
机构
[1] Univ Milan, Dept Biol, I-20133 Milan, Italy
[2] Univ Milan, Genet Med Fac, I-20133 Milan, Italy
[3] Niguarda Hosp, Div Hematol, Milan, Italy
关键词
D O I
10.1016/S0165-4608(00)00362-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Trisomy 12 and deletions of 13q14.2 and 14q32 are the most common chromosome abnormalities in patients with B-chronic lymphocytic leukemia (B-CLL), but whether specific chromosomal defects influence the course of B-CLL is still a matter of discussion. The aim of our study was to assess the possible correlation between cytogenetic findings and clinical characteristics. Thirty patients with previously untreated early-onset B-CLL were recruited. The incidence of trisomy 12, and observations of 13q14.2 and 14q32 was analyzed in unstimulated bone marrow cells by means of multicolor interphase FISH. No correlation was found between trisomy 12 and the patients' clinical characteristics. The analysis of the patients with trisomy 12 and observations of 13q14.2 and 14q32 revealed heterogeneity of the leukemic cell population, thus indicating that these chromosomal abnormalities are probably a secondary event in CLL leukemogenesis. The finding of RB1 gene nullisomy and 14q32 deletions in patients at an advanced clinical stage suggests a possible correlation between these rearrangements and disease progression. Multicolor FISH analysis in B-CLL provides important diagnostic, clinical, and prognostic information that may help in assessing prognosis and making treatment decisions. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:63 / 69
页数:7
相关论文
共 23 条
[1]   Detection of trisomy 12 and centromeric alterations in CLL by interphase- and metaphase-FISH [J].
Acar, H ;
Connor, MJ .
CANCER GENETICS AND CYTOGENETICS, 1998, 100 (02) :148-151
[2]  
AUTIO K, 1987, EUR J HAEMATOL, V39, P289
[3]  
BINET JL, 1977, CANCER-AM CANCER SOC, V40, P855, DOI 10.1002/1097-0142(197708)40:2<855::AID-CNCR2820400239>3.0.CO
[4]  
2-1
[5]  
CANAO I, 1996, CANCER GENET CYTOGEN, V90, P118
[6]  
CHAPMAN RM, 1994, ONCOGENE, V9, P1289
[7]   GUIDELINES FOR CLINICAL PROTOCOLS FOR CHRONIC LYMPHOCYTIC-LEUKEMIA - RECOMMENDATIONS OF THE NATIONAL-CANCER-INSTITUTE-SPONSORED-WORKING-GROUP [J].
CHESON, BD ;
BENNETT, JM ;
RAI, KR ;
GREVER, MR ;
KAY, NE ;
SCHIFFER, CA ;
OKEN, MM ;
KEATING, MJ ;
BOLDT, DH ;
KEMPIN, SJ ;
FOON, KA .
AMERICAN JOURNAL OF HEMATOLOGY, 1988, 29 (03) :152-163
[8]   Genes and chromosomes in chronic B-cell leukemia [J].
Crossen, PE .
CANCER GENETICS AND CYTOGENETICS, 1997, 94 (01) :44-51
[9]   Genetic abnormalities in chronic lymphocytic leukemia and their clinical and prognostic implications [J].
Dierlamm, J ;
Michaux, L ;
Criel, A ;
Wlodarska, I ;
VandenBerghe, H ;
Hossfeld, DK .
CANCER GENETICS AND CYTOGENETICS, 1997, 94 (01) :27-35
[10]   Chromosome aberrations in B-cell chronic lymphocytic leukemia:: reassessment based on molecular cytogenetic analysis [J].
Döhner, H ;
Stilgenbauer, S ;
Döhner, K ;
Bentz, M ;
Lichter, P .
JOURNAL OF MOLECULAR MEDICINE-JMM, 1999, 77 (02) :266-281